Glucotrack, Inc. — Form 8-K/A
Filed October 13, 2026 · analyzed by the 8-K Agent
8-K/A
▼ Likely negative
significance 87/100
What the filing says
On July 14, 2026, Glucotrack merged with Lokahi Therapeutics in an all-stock transaction valued at $33.3M, with former Lokahi shareholders receiving 90% of combined equity. Glucotrack simultaneously raised $4.45M in convertible notes (22% OID, 8% coupon, due April 2027) and $3.5M in follow-on convertible notes (same terms, due May 2027), plus $2M equity PIPE at $11.25/share. The merger created $40.1M in intangible assets and goodwill. Pro forma H1 2026 net loss was $19.7M on zero revenue; pro forma 2025 net loss was $28.1M on zero revenue.
Why this rating
Massive acquisition (equity issuance ~$33M = 611% of $5.4M market cap) plus $7.95M debt financing on company with zero revenue and $19.7M H1 losses. 1-for-15 reverse split signals distress. Transforms capital structure and ownership; material going-concern risk.
Tradability signal
NO TRADE
No trade: only ~$75k traded in the last 30 min — too illiquid to enter and exit. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $1.12 ▲ 2.76% | at our read · unknown $1.09 | +10 min · unknown $1.09 ▼ 0.28% | +30 min · unknown $1.05 ▼ 3.49% | +1 hr · unknown $1.02 ▼ 6.51% | +4 hrs · unknown $0.86 ▼ 20.83% |
The stock had already moved -2.69% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.